Clinical Trials Directory

Trials / Completed

CompletedNCT03324893

FCH PET/MRI Parathyroid Localization

18F-Fluorocholine PET/MRI for the Localization of Parathyroid Adenomas

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
47 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective trial comparing the accuracy of \[F-18\]-FCH PET/MRI to US and 99mTc-MIBI SPECT/CT for pre-operative parathyroid localization in patients with primary hyperparathyroidism

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST[F-18]-FCH PET/MRISubjects will undergo the \[F-18\]-FCH PET/MRI within three months prior to scheduled parathyroidectomy.

Timeline

Start date
2018-04-03
Primary completion
2021-06-23
Completion
2021-06-23
First posted
2017-10-30
Last updated
2023-12-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03324893. Inclusion in this directory is not an endorsement.

FCH PET/MRI Parathyroid Localization (NCT03324893) · Clinical Trials Directory